title: Role of chemotherapy in the treatment of infantile fibrosarcoma.
authors.affiliation: Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California 94305-5208, USA. avishetty@pol.net
authors.forename: A K
authors.initials: AK
authors.lastname: Shetty
authors.forename: L C
authors.initials: LC
authors.lastname: Yu
authors.forename: R V
authors.initials: RV
authors.lastname: Gardner
authors.forename: R P
authors.initials: RP
authors.lastname: Warrier
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000601:surgery; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003609:Dactinomycin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D016190:Carboplatin; D015080:Mesna; D007069:Ifosfamide